Incyte (INCY) Shares Outstanding (Diluted) (2010 - 2026)
Incyte's Shares Outstanding (Diluted) came in at 208.22 million for Q2 2026, up 4.8% from 198.74 million a year earlier and up 0.7% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
For FY2025, Incyte's Shares Outstanding (Diluted) was 200.7 million, down 4.7% from FY2024.
- Shares Outstanding (Diluted) carries a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Diluted) was 210.53 million in FY2024 (-6.8%), 225.93 million in FY2023 (+0.9%), 223.96 million in FY2022 (+0.8%) and 222.07 million in FY2021 (+1.8%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) since Q4 2024.
- Year-over-year, Shares Outstanding (Diluted) increased in three of the last eight quarters, with an average decline of 4.3%.
- The fastest year-over-year change in Shares Outstanding (Diluted) over five years came in Q2 2026 (growth of 4.8%), and the weakest in Q3 2024 (a decline of 13.4%).
- Business Quant data shows INCY's Shares Outstanding (Diluted) at 206.83 million (Q1 2026), 200.7 million (Q4 2025) and 201.43 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Incyte | 23.54 Bn | 8.48 Bn | 1.57 Bn | 208.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 208.22 Mn |
| Mar 31, 2026 | 206.83 Mn |
| Dec 31, 2025 | 200.70 Mn |
| Sep 30, 2025 | 201.43 Mn |
| Jun 30, 2025 | 198.74 Mn |
| Mar 31, 2025 | 198.20 Mn |
| Dec 31, 2024 | 210.53 Mn |
| Sep 30, 2024 | 195.84 Mn |
| Jun 30, 2024 | 218.18 Mn |
| Mar 31, 2024 | 227.22 Mn |
| Dec 31, 2023 | 225.93 Mn |
| Sep 30, 2023 | 226.17 Mn |
| Jun 30, 2023 | 225.65 Mn |
| Mar 31, 2023 | 225.59 Mn |
| Dec 31, 2022 | 223.96 Mn |
| Sep 30, 2022 | 224.18 Mn |
| Jun 30, 2022 | 223.66 Mn |
| Mar 31, 2022 | 222.95 Mn |
| Dec 31, 2021 | 222.07 Mn |
| Sep 30, 2021 | 222.25 Mn |
API Access
Incyte Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();